Pravin Dugel - 28 Apr 2025 Form 4 Insider Report for OCULAR THERAPEUTIX, INC (OCUL)

Role
Executive Chairman, President and CEO, Director
Signature
/s/ Todd Anderman, Attorney-in-Fact for Pravin Dugel
Issuer symbol
OCUL
Transactions as of
28 Apr 2025
Net transactions value
$0
Form type
4
Filing time
13 Aug 2025, 19:02:24 UTC
Previous filing
26 Feb 2025
Next filing
27 May 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Dugel Pravin Executive Chairman, President and CEO, Director C/O OCULAR THERAPEUTIX, INC., 15 CROSBY DRIVE, BEDFORD /s/ Todd Anderman, Attorney-in-Fact for Pravin Dugel 13 Aug 2025 0001700917

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCUL Common Stock Gift $0 -200,332 -5.7% $0.000000 3,298,767 28 Apr 2025 Direct F1
transaction OCUL Common Stock Gift $0 -50,029 -1.5% $0.000000 3,248,738 12 Jun 2025 Direct F2
transaction OCUL Common Stock Gift $0 +250,361 $0.000000 250,361 11 Aug 2025 By Pravin Dugel 2024 Irrevocable Trust F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On April 28, 2025, the reporting person transferred 200,332 shares to his spouse for no consideration.
F2 On June 12, 2025, the reporting person transferred 50,029 shares to his spouse for no consideration.
F3 On August 11, 2025, the reporting person's spouse transferred 250,361 shares to the Pravin Dugel 2024 Irrevocable Trust (the "Trust") for no consideration. The reporting person is trustee of the Trust and sole beneficiary of the Trust during his lifetime. The reporting person remains the beneficial owner of the securities held by the Trust.

Remarks:

Executive Chairman, President and CEO